FOXA2
Hepatocyte nuclear factor 3-beta
Also known as: FOXA2_HUMAN, HNF3B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y261
- Gene
- FOXA2
- Ensembl
- ENSG00000125798
- Chromosome
- 20
- Canonical length
- 457 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cell Junctions
OverviewNCBI Gene
This gene encodes a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific genes such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. This gene has been linked to sporadic cases of maturity-onset diabetes of the young. Transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
457 residues, UniProt reviewed canonical sequence.
>Q9Y261|FOXA2
1 MLGAVKMEGH EPSDWSSYYA EPEGYSSVSN MNAGLGMNGM NTYMSMSAAA MGSGSGNMSA
61 GSMNMSSYVG AGMSPSLAGM SPGAGAMAGM GGSAGAAGVA GMGPHLSPSL SPLGGQAAGA
121 MGGLAPYANM NSMSPMYGQA GLSRARDPKT YRRSYTHAKP PYSYISLITM AIQQSPNKML
181 TLSEIYQWIM DLFPFYRQNQ QRWQNSIRHS LSFNDCFLKV PRSPDKPGKG SFWTLHPDSG
241 NMFENGCYLR RQKRFKCEKQ LALKEAAGAA GSGKKAAAGA QASQAQLGEA AGPASETPAG
301 TESPHSSASP CQEHKRGGLG ELKGTPAAAL SPPEPAPSPG QQQQAAAHLL GPPHHPGLPP
361 EAHLKPEHHY AFNHPFSINN LMSSEQQHHH SHHHHQPHKM DLKAYEQVMH YPGYGSPMPG
421 SLAMGPVTNK TGLDASPLAA DTSYYQGVYS RPIMNSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FOXA2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- liver: 35 nTPM
- stomach: 29 nTPM
- pancreas: 25 nTPM
- cervix: 13 nTPM
- lung: 13 nTPM
- rectum: 8.9 nTPM
Single-cell type
- foveolar cells: 103 nCPM
- parietal cells: 88 nCPM
- goblet cells: 81 nCPM
- hepatocytes: 77 nCPM
- fallopian tube ciliated cells: 77 nCPM
- alveolar cells type 1: 70 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 5.5 nTPM
- thalamus: 1.1 nTPM
- pons: 0.2 nTPM
- spinal cord: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FOXA2.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 179 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital syndromic hypopituitarism
- Non-acquired combined pituitary hormone deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.74
- gnomAD missense Z
- 0.38
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult locomotory behavior
- anatomical structure morphogenesis
- cell differentiation
- cell fate specification
- chromatin organization
- dopaminergic neuron differentiation
- endocrine pancreas development
- negative regulation of epithelial to mesenchymal transition
- negative regulation of transcription by RNA polymerase II
- positive regulation of cell-cell adhesion mediated by cadherin
- positive regulation of DNA-templated transcription
- positive regulation of embryonic development
- positive regulation of gastrulation
- positive regulation of transcription by RNA polymerase II
- primitive streak formation
- regulation of blood coagulation
- regulation of insulin secretion involved in cellular response to glucose stimulus
- regulation of transcription by RNA polymerase II
- response to interleukin-6
Molecular functions
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- nucleic acid binding
- protein domain specific binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
- transcription corepressor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Fork head domain
- Fork-head N-terminal
- Fork head domain conserved site1
- Forkhead box protein, C-terminal
- Fork head domain conserved site 2
- Winged helix-like DNA-binding domain superfamily
- Winged helix DNA-binding domain superfamily
- Forkhead box domain-containing protein
- Forkhead domain
- Forkhead N-terminal region
- HNF3 C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FOXA2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FOXA2 as an antibody target. Whether an autoantibody or antibody against FOXA2 could matter depends on whether native FOXA2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FOXA2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FOXA2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...